| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Ovid Therapeutics, Inc.(OVID) | 7,531,996 | $9.8M | 59.82% |
| 2 | Equillium, Inc.(EQ) | 1,824,977 | $2.6M | 15.94% |
| 3 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)(XLO) | 1,475,121 | $1.2M | 7.59% |
| 4 | Shattuck Labs, Inc.(STTK) | 515,619 | $1.2M | 7.53% |
| 5 | Lyell Immunopharma, Inc. | 54,887 | $891.4K | 5.45% |
| 6 | American Well Corporation(AMWL) | 77,733 | $478.1K | 2.92% |
| 7 | Rani Therapeutics Holdings, Inc.(RANI) | 203,190 | $101.6K | 0.62% |
| 8 | Standard Biotools, Inc.(LAB) | 16,515 | $21.5K | 0.13% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 27.04% | 94.55% | +67.51% |
| Unclassified | 72.96% | 5.45% | -67.51% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Micro Cap | 19.72% | 79.3% | +59.58% |
| Small Cap | 7.32% | 15.25% | +7.93% |
| Unclassified | 72.96% | 5.45% | -67.51% |
Quarter-over-quarter position changes